Insider Transactions in Q4 2022 at Impel Pharmaceuticals Inc (IMPL)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2022
|
John Harold Leaman Chief Fin. & Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,627
-34.31%
|
$10,881
$3.75 P/Share
|
|
Dec 31
2022
|
John Harold Leaman Chief Fin. & Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,571
+50.0%
|
-
|